Karen van Gorp was diagnosed with stage IV melanoma in 2013 and survived through a clinical trial for a new class of treatment. She is Chair of Cancer Voices SA and an executive member of Cancer Voices Australia, where she works to strengthen consumer involvement in health technology assessment (HTA).

Karen also Co-Chairs the Consumer Advisory Group to Melanoma Patients Australia and serves as Deputy Chair of its Board. In these roles, she focuses on education and organisation to empower consumers to engage effectively in HTA and policy development. She is also on the SA Comprehensive Cancer Network Committee and is a Senior Policy Adviser for the SA Business Chamber.

Karen van Gorp
Melanoma Patients Australia https://melanomapatients.org.au/
Cancer Voices SA https://cancervoicessa.org.au/
Cancer Voices Australia https://www.cancervoicesaustralia.org/


Our work at Patient Voice Initiative is only possible thanks to the generous support of our Sponsors; for a full list of both our Gold and Silver contributors, please visit our Website. 

Find out more about PVI by visiting our website https://www.patientvoiceinitiative.org/